AstraZeneca is a pharmaceutical company based in Cambridge, England, that discovers, develops and sells prescription medicines. Its business focuses on therapy areas such as cancer, cardiovascular and metabolic disease, respiratory illness and immunology. The company supplies hospitals, clinics, physicians and health systems in markets around the world, and it also produces vaccines and other biologic treatments through its research and manufacturing operations.
The shares are listed on the London Exchange in UK under the code AZN, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1703 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
37/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-4.0%
From 52-week high-17.5%
MomentumWeak
46/100
Lagging most stocks on this exchange.
See the numbers →
3-month return1.7%
6-month return-10.9%
12-month, skipping last month1.2%
Stability (higher is calmer)Fair
64/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)26.7%
Worst drawdown, 1 year (smaller is calmer)-26.0%
LiquidityStrong
100/100
Trades actively.
See the numbers →
Avg daily value traded40,262.38M GBX
Zero-volume days0.0%
IncomeWeak
36/100
Dividend is small or irregular.
See the numbers →
Dividend yield1.9%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 9,892.00 – 15,732.00Daily closes, split-adjusted
Signals
50-day average12,177.52
200-day average13,362.01
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)303.31
Technical summary
Daily
Bullish
11 bullish · 1 neutral · 4 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
12,480.2
Bullish
EMA 10
12,551.9
Bullish
SMA 20
12,284.8
Bullish
EMA 20
12,399.7
Bullish
SMA 50
12,177.5
Bullish
EMA 50
12,346.3
Bullish
SMA 100
12,587.6
Bullish
EMA 100
12,582.9
Bullish
SMA 200
13,362.0
Bearish
EMA 200
12,782.9
Bullish
Oscillators (daily)
RSI (14)
60.15
Neutral
MACD (12, 26)
151.2
Bullish
Momentum (12)
5.29
Bullish
Stochastic %K (14)
86.98
Bearish
Williams %R (14)
-13.02
Bearish
CCI (20)
122.1
Bearish
Pivot points (classic, last session)
S3
12,461.3
S2
12,566.7
S1
12,695.3
Pivot
12,800.7
R1
12,929.3
R2
13,034.7
R3
13,163.3
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.39 GBP
Yield on today's price
1.86%
Frequency
Semi-annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.7950
1.5950
0.7670
1.6800
0.7760
1.5600
0.7180
1.6280
0.7640
1.4530
0.6480
1.3740
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
